The Experts below are selected from a list of 88797 Experts worldwide ranked by ideXlab platform
David H. Barad - One of the best experts on this subject based on the ideXlab platform.
-
Utilization of third-party in Vitro Fertilization in the United States.
American Journal of Obstetrics and Gynecology, 2017Co-Authors: Vitaly A. Kushnir, David H. Barad, Sarah K. Darmon, Alice J. Shapiro, David F. Albertini, Norbert GleicherAbstract:The use of in Vitro Fertilization that includes third-party in Vitro Fertilization is increasing. However, the relative contribution of third-party in Vitro Fertilization that includes the use of donor oocytes, sperm, or embryo and a gestational carrier to the birth cohort after in Vitro Fertilization is unknown. The purpose of this study was to examine the contribution of third-party in Vitro Fertilization to the in Vitro Fertilization birth cohort over the past decade. This retrospective analysis investigated 1,349,874 in Vitro Fertilization cycles that resulted in 421,525 live births and 549,367 liveborn infants in the United States from 2004-2013. Cycles were self-reported by fertility centers to a national registry: Society for Assisted Reproductive Technologies Clinic Outcome Reporting System. Third-party in Vitro Fertilization accounted for 217,030 (16.1%) of all in Vitro Fertilization cycles, 86,063 (20.4%) of all live births, and 115,024 (20.9%) of all liveborn infants. Overall, 39.7% of third-party in Vitro Fertilization cycles resulted in a live birth, compared with 29.6% of autologous in Vitro Fertilization cycles. Use of third-party in Vitro Fertilization increased with maternal age and accounted for 42.2% of all in Vitro Fertilization cycles and 75.3% of all liveborn infants among women >40 years old. Oocyte donation was the most common third-party in Vitro Fertilization technique, followed by sperm donation. Over the study period, annual cycle volume and live birth rates gradually increased for both autologous in Vitro Fertilization and third-party in Vitro Fertilization (P<.0001 for all). Live birth rates were the highest when multiple third-party in Vitro Fertilization modalities were used, followed by oocyte donation. Third-party in Vitro Fertilization use and efficacy have increased over the past decade, now comprising >20% of the total in Vitro Fertilization birth cohort. in women who are >40 years old, third-party in Vitro Fertilization has become the dominant treatment. Copyright © 2016 Elsevier inc. All rights reserved.
-
Utilization of third-party in Vitro Fertilization in the United States
American Journal of Obstetrics and Gynecology, 2016Co-Authors: Vitaly A. Kushnir, David H. Barad, Sarah K. Darmon, Alice J. Shapiro, David F. Albertini, Norbert GleicherAbstract:Background The use of in Vitro Fertilization that includes third-party in Vitro Fertilization is increasing. However, the relative contribution of third-party in Vitro Fertilization that includes the use of donor oocytes, sperm, or embryo and a gestational carrier to the birth cohort after in Vitro Fertilization is unknown. Objective The purpose of this study was to examine the contribution of third-party in Vitro Fertilization to the in Vitro Fertilization birth cohort over the past decade. Study Design This retrospective analysis investigated 1,349,874 in Vitro Fertilization cycles that resulted in 421,525 live births and 549,367 liveborn infants in the United States from 2004–2013. Cycles were self-reported by fertility centers to a national registry: Society for Assisted Reproductive Technologies Clinic Outcome Reporting System. Results Third-party in Vitro Fertilization accounted for 217,030 (16.1%) of all in Vitro Fertilization cycles, 86,063 (20.4%) of all live births, and 115,024 (20.9%) of all liveborn infants. Overall, 39.7% of third-party in Vitro Fertilization cycles resulted in a live birth, compared with 29.6% of autologous in Vitro Fertilization cycles. Use of third-party in Vitro Fertilization increased with maternal age and accounted for 42.2% of all in Vitro Fertilization cycles and 75.3% of all liveborn infants among women >40 years old. Oocyte donation was the most common third-party in Vitro Fertilization technique, followed by sperm donation. Over the study period, annual cycle volume and live birth rates gradually increased for both autologous in Vitro Fertilization and third-party in Vitro Fertilization ( P Conclusion Third-party in Vitro Fertilization use and efficacy have increased over the past decade, now comprising >20% of the total in Vitro Fertilization birth cohort. in women who are >40 years old, third-party in Vitro Fertilization has become the dominant treatment.
-
in Vitro Fertilization (IVF)
Encyclopedia of Endocrine Diseases, 2004Co-Authors: David H. BaradAbstract:in Vitro Fertilization is the Fertilization of oocytes in a laboratory. in Vitro literally means “in glass.” in Vitro Fertilization and other procedures used to allow Fertilization outside the female reproductive system are collectively known as assisted reproductive technologies.
Philippe Brouqui - One of the best experts on this subject based on the ideXlab platform.
-
congenital tuberculosis after in Vitro Fertilization
Pediatric Infectious Disease Journal, 2008Co-Authors: Barbara Doudier, Emilie Mosnier, Clarisse Rovery, Marion Uters, Claude Dercole, Philippe BrouquiAbstract:Genital tuberculosis (TB) is a major cause of infertility in the world, notably in developing countries, but its incidence is increasing in the western continents. in Vitro Fertilization (IVF) represents a useful treatment of infertility after TB. We report the first case of congenital TB after IVF and suggest improvement of usual screening before and after IVF.
Frauke Von Versenhoynck - One of the best experts on this subject based on the ideXlab platform.
-
increased preeclampsia risk and reduced aortic compliance with in Vitro Fertilization cycles in the absence of a corpus luteum
Hypertension, 2019Co-Authors: Kueihsun Chiu, Melissa Lingis, Stan R Williams, Alice Rhotonvlasak, Wilmer W Nichols, Frauke Von Versenhoynck, Amelia Schaub, Raquel R Fleischmann, Wendy Y ZhangAbstract:in Vitro Fertilization involving frozen embryo transfer and donor oocytes increases preeclampsia risk. These in Vitro Fertilization protocols typically yield pregnancies without a corpus luteum (CL...
Norbert Gleicher - One of the best experts on this subject based on the ideXlab platform.
-
Utilization of third-party in Vitro Fertilization in the United States.
American Journal of Obstetrics and Gynecology, 2017Co-Authors: Vitaly A. Kushnir, David H. Barad, Sarah K. Darmon, Alice J. Shapiro, David F. Albertini, Norbert GleicherAbstract:The use of in Vitro Fertilization that includes third-party in Vitro Fertilization is increasing. However, the relative contribution of third-party in Vitro Fertilization that includes the use of donor oocytes, sperm, or embryo and a gestational carrier to the birth cohort after in Vitro Fertilization is unknown. The purpose of this study was to examine the contribution of third-party in Vitro Fertilization to the in Vitro Fertilization birth cohort over the past decade. This retrospective analysis investigated 1,349,874 in Vitro Fertilization cycles that resulted in 421,525 live births and 549,367 liveborn infants in the United States from 2004-2013. Cycles were self-reported by fertility centers to a national registry: Society for Assisted Reproductive Technologies Clinic Outcome Reporting System. Third-party in Vitro Fertilization accounted for 217,030 (16.1%) of all in Vitro Fertilization cycles, 86,063 (20.4%) of all live births, and 115,024 (20.9%) of all liveborn infants. Overall, 39.7% of third-party in Vitro Fertilization cycles resulted in a live birth, compared with 29.6% of autologous in Vitro Fertilization cycles. Use of third-party in Vitro Fertilization increased with maternal age and accounted for 42.2% of all in Vitro Fertilization cycles and 75.3% of all liveborn infants among women >40 years old. Oocyte donation was the most common third-party in Vitro Fertilization technique, followed by sperm donation. Over the study period, annual cycle volume and live birth rates gradually increased for both autologous in Vitro Fertilization and third-party in Vitro Fertilization (P<.0001 for all). Live birth rates were the highest when multiple third-party in Vitro Fertilization modalities were used, followed by oocyte donation. Third-party in Vitro Fertilization use and efficacy have increased over the past decade, now comprising >20% of the total in Vitro Fertilization birth cohort. in women who are >40 years old, third-party in Vitro Fertilization has become the dominant treatment. Copyright © 2016 Elsevier inc. All rights reserved.
-
Utilization of third-party in Vitro Fertilization in the United States
American Journal of Obstetrics and Gynecology, 2016Co-Authors: Vitaly A. Kushnir, David H. Barad, Sarah K. Darmon, Alice J. Shapiro, David F. Albertini, Norbert GleicherAbstract:Background The use of in Vitro Fertilization that includes third-party in Vitro Fertilization is increasing. However, the relative contribution of third-party in Vitro Fertilization that includes the use of donor oocytes, sperm, or embryo and a gestational carrier to the birth cohort after in Vitro Fertilization is unknown. Objective The purpose of this study was to examine the contribution of third-party in Vitro Fertilization to the in Vitro Fertilization birth cohort over the past decade. Study Design This retrospective analysis investigated 1,349,874 in Vitro Fertilization cycles that resulted in 421,525 live births and 549,367 liveborn infants in the United States from 2004–2013. Cycles were self-reported by fertility centers to a national registry: Society for Assisted Reproductive Technologies Clinic Outcome Reporting System. Results Third-party in Vitro Fertilization accounted for 217,030 (16.1%) of all in Vitro Fertilization cycles, 86,063 (20.4%) of all live births, and 115,024 (20.9%) of all liveborn infants. Overall, 39.7% of third-party in Vitro Fertilization cycles resulted in a live birth, compared with 29.6% of autologous in Vitro Fertilization cycles. Use of third-party in Vitro Fertilization increased with maternal age and accounted for 42.2% of all in Vitro Fertilization cycles and 75.3% of all liveborn infants among women >40 years old. Oocyte donation was the most common third-party in Vitro Fertilization technique, followed by sperm donation. Over the study period, annual cycle volume and live birth rates gradually increased for both autologous in Vitro Fertilization and third-party in Vitro Fertilization ( P Conclusion Third-party in Vitro Fertilization use and efficacy have increased over the past decade, now comprising >20% of the total in Vitro Fertilization birth cohort. in women who are >40 years old, third-party in Vitro Fertilization has become the dominant treatment.
Wilmer W Nichols - One of the best experts on this subject based on the ideXlab platform.
-
maternal cardiovascular dysregulation during early pregnancy after in Vitro Fertilization cycles in the absence of a corpus luteum
Hypertension, 2019Co-Authors: Kirk P Conrad, John W Petersen, Xiaoman Zhai, Minjie Li, Kueihsun Chiu, Melissa Lingis, Stan R Williams, Alice Rhotonvlasak, Joseph J Larocca, Wilmer W NicholsAbstract:Commonly used in Vitro Fertilization protocols produce pregnancies without a corpus luteum (CL), a major source of reproductive hormones. in Vitro Fertilization pregnancies without a CL showed defi...
-
increased preeclampsia risk and reduced aortic compliance with in Vitro Fertilization cycles in the absence of a corpus luteum
Hypertension, 2019Co-Authors: Kueihsun Chiu, Melissa Lingis, Stan R Williams, Alice Rhotonvlasak, Wilmer W Nichols, Frauke Von Versenhoynck, Amelia Schaub, Raquel R Fleischmann, Wendy Y ZhangAbstract:in Vitro Fertilization involving frozen embryo transfer and donor oocytes increases preeclampsia risk. These in Vitro Fertilization protocols typically yield pregnancies without a corpus luteum (CL...
